EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›NGVT

NGVT

Ingevity Corp

Next earnings Aug 3, 2026 · consensus $1.37 EPS, $311M rev

Last earnings +1.0% on 2026-05-06

Avoid
$77.12
▲ +3.98%
$77.12▲ +86.69%
over 1Y
L $40.40EODHDH $77.87
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.0%
1W+6.0%
1M+11.9%
3M+9.3%
YTD+28.3%
1Y+86.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
C
Valuation
Fair value
Filings
Watch
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Buy

Revenue declined -2.7% YoY.

Ingevity Corp shows $1.17B in FY2025 revenue (-2.7% YoY), a -14.3% net margin, and -562.6% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.39B$1.67B$1.22B$1.20B$1.17B
Gross profit$513M$570M$445M$465M$462M
Operating income$422M$453M$423M$426M$419M
Net income$118M$212M-$5.40M-$430M-$167M
Diluted EPS$2.95$5.50-$0.15-$11.85-$4.61
Net margin8.5%12.7%-0.4%-35.9%-14.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.69B
EV / EBITDA5.1
EV / Sales2.3
EV / FCF9.8
P / FCF10.0
PEG (trailing)—
Earnings yield-6.1%
FCF yield10.0%

Quality & risk

ROIC (est.)430.7%
Free cash flow$274M
Total debt$47.1M
Net cash$31.0M
Altman Z-Score2.98 grey
Piotroski F-Score6/8

Capital returns

Buyback yield2.1%
Dividend yield (est.)—
Shareholder yield2.1%
Shares Δ YoY-2.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-06-24
  2. 10-Q Quarterly report2026-05-07
  3. 8-K Earnings results2026-05-06
  4. 8-K Officer / director change2026-05-04
  5. 8-K Reg FD disclosure2026-04-15
  6. 8-K Material agreement2026-03-30
  7. DEF 14A Proxy statement2026-03-17
  8. 10-K Annual report2026-02-26
  9. 8-K Earnings results2026-02-25

Recent filings

all on EDGAR ↗
4Period ending 2026-06-222026-06-24open ↗3Period ending 2026-06-222026-06-24open ↗8-KPeriod ending 2026-06-222026-06-24open ↗4Period ending 2026-05-282026-06-01open ↗SCHEDULE 13G/AFiling2026-05-15open ↗S-8Filing2026-05-07open ↗10-QPeriod ending 2026-03-312026-05-07open ↗8-KPeriod ending 2026-05-062026-05-06open ↗4Period ending 2026-05-012026-05-05open ↗8-KPeriod ending 2026-04-292026-05-04open ↗4Period ending 2026-04-302026-05-01open ↗4Period ending 2026-04-302026-05-01open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueB
GrowthB-
ProfitabilityD
Financial healthD
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
Revenue
$1.17B
-2.7% YoY
Net margin
-14.3%
ROE
-562.6%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.17B-2.7%
Net income-$167M+61.2%
Gross profit$462M-0.7%
Operating income$419M-1.7%
Diluted EPS-$4.61+61.1%
Cash & equivalents$78.1M+14.9%
Total assets$1.65B-18.4%
Total liabilities$1.62B-11.3%
Stockholders' equity$29.7M-84.8%
Gross: 39.5%Op.: 35.9%L/E: 54.59x

Frequently asked

Is Ingevity Corp (NGVT) a buy?
NGVT currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Revenue declined -2.7% YoY.
What is Ingevity Corp's quality score?
NGVT scores 55.882352941176464/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001653477, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 7:05:13 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 3 sales

2026-06-22
Cotterman Ryan Joseph
VP, Chief Accounting Officer
Award2.06K
2026-05-28
DYER TERRANCE M
SVP, Chief HR Officer
Sell266.00 @ $68.45$18.2K
2026-05-28
DYER TERRANCE M
SVP, Chief HR Officer
Sell30.00 @ $68.57$2.06K
2026-05-28
DYER TERRANCE M
SVP, Chief HR Officer
Sell200.00 @ $68.53$13.7K
2026-05-01
PLATT PHILLIP JOHN
SVP, Finance & CAO
Award1.26K
2026-04-30
FERNANDEZ-MORENO LUIS M
Director
Award1.90K
2026-04-30
Gulyas Diane H.
Director
Award1.90K
2026-04-30
Hoechner Bruce D.
Director
Award1.90K
2026-04-30
Lynch Frederick J
Director
Award1.90K
2026-04-30
NARWOLD KAREN G
Director
Award1.90K

Earnings history

beat/miss · move
2026-05-06Beat +45.0% est▲ +1.00%8-K ↗
2026-02-25Miss -10.2% est▼ -2.14%8-K ↗
2025-11-05Beat +7.2% est▲ +3.58%8-K ↗
2025-08-04Beat +17.2% est▲ +1.11%8-K ↗
2025-05-05—▲ +1.37%8-K ↗
2025-02-18—▲ +1.64%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Dentsply Sirona Appoints John Fortson as Chief Financial OfficerBullish
finance.yahoo.com· 2026-06-11
Ingevity (NGVT) Q1 2026 Earnings TranscriptBullish
nasdaq.com· 2026-06-01
Ingevity (NGVT) Beats Q1 Earnings and Revenue EstimatesBullish
finance.yahoo.com· 2026-05-06
Ingevity Stockholders Approve All Proposals at 2026 Annual Meeting; CEO Targets $1B Deployable CashBullish
finance.yahoo.com· 2026-05-03
RBC Capital Bullish on PPG Industries (PPG) – Raises Price TargetBullish
finance.yahoo.com· 2026-04-21
NGVT Sells Ozark Materials to PPG to Streamline Core OperationsBullish
finance.yahoo.com· 2026-04-16

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score56 vs 67
Revenue growth-2.7% vs 7.1%
Net margin-14.3% vs 10.5%
Return on equity-562.6% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 4d
Bullish
+0.18
vs typical · 4 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.